BEGIN:VCALENDAR

VERSION:2.0

PRODID:-//wp-events-plugin.com//7.2.2.1//EN

TZID:Asia/Jerusalem

X-WR-TIMEZONE:Asia/Jerusalem
BEGIN:VEVENT

UID:1215@biology.technion.ac.il

DTSTART;TZID=Asia/Jerusalem:20240403T130000

DTEND;TZID=Asia/Jerusalem:20240403T140000

DTSTAMP:20240331T083602Z

URL:https://biology.technion.ac.il/en/seminars/bridge-to-industry-1-beyond
 -birth-exploring-placental-potential-in-biomedical-innovation/

SUMMARY:PhD Graduate Seminar- Guy Levin [No Categories]
DESCRIPTION:Location: Hybrid- in the Faculty Auditorium/ZOOM: https://techn
 ion.zoom.us/j/2085309787   Guy Levin\n Affiliation: CSO\, Pluri \n Host:Pr
 ofessor Emeritus Schuster Gadi\, Associate Prof. Yehezkeli Omer\n Bridge t
 o Industry\nA lecture series fostering collaboration between academia and 
 industry. The Faculty of Biology is proud to present a series of meetings 
 focused on groundbreaking research and innovation in Israel's life science
 s industry.\n\nJoin us as leading researchers and entrepreneurs discuss ch
 allenges and solutions\, fostering a dynamic community for:\n\n 	Enhanced 
 Collaboration between academia and industry\n 	Building a Thriving Innovat
 ion Ecosystem with researchers\, entrepreneurs\, and students\n 	Advancing
  Applied Knowledge and breakthrough technologies in biotechnology\n\n## Le
 cture 1: Pluri - Beyond Birth: Exploring Placental Potential in Biomedical
  Innovation\n\nSpeaker: Dr. Arthur Machlenkin\, CSO of Pluri\n\nAbstract:\
 n\nPluri\, an Israeli clinical-stage company\, is pioneering the developme
 nt of innovative cell products derived from the placenta. This study inves
 tigates the potential of Placenta eXpanded (PLX) mesenchymal-like stromal 
 cells for regenerative medicine applications. Characterized by their uniqu
 e secretome\, PLX cells possess distinct immunomodulatory and regenerative
  capabilities\, making them promising candidates for therapeutic intervent
 ions. Specifically\, this research delves into the therapeutic potential o
 f PLX cells in treating acute radiation syndrome (ARS)\, capitalizing on t
 heir allogeneic nature and support for hematopoietic recovery. Additionall
 y\, Pluri explores the placenta as a source of non-conventional immune cel
 ls\, which can be genetically modified to confer specificity against cance
 r antigens\, thereby enhancing the efficacy of allogeneic immunotherapy of
  cancer. By concurrently investigating these avenues\, this study aims to 
 unlock the full therapeutic potential of placenta-derived cells\, presenti
 ng innovative strategies for both regenerative medicine and cancer treatme
 nt.\n\nDon't miss this opportunity to connect and inspire!\n\n\n\n\n\n\n\n
 \n\n\n\n\nPlease secure your spot for the lecture via the link: https://di
 d.li/vEwrl\n\n\n\n\n\n\n\n\n\n\n\n 
LOCATION:Hybrid- in the Faculty Auditorium/ZOOM: https://technion.zoom.us/j
 /2085309787

END:VEVENT

BEGIN:VTIMEZONE

TZID:Asia/Jerusalem

X-LIC-LOCATION:Asia/Jerusalem

BEGIN:DAYLIGHT

DTSTART:20240329T030000

TZOFFSETFROM:+0200

TZOFFSETTO:+0300

TZNAME:IDT

END:DAYLIGHT

END:VTIMEZONE
END:VCALENDAR